Matthew McBrady left the role of Director at Axon Enterprise, Inc. As of November 6, 2026, Axon Enterprise, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 10, 2026 to July 10, 2026, naming 1 departure (Form 8-K, April 10, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Axon Enterprise, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Axon Enterprise, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-10 to 2026-07-10. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Axon Enterprise, Inc. files it.
Also on the record for Axon Enterprise, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.23% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 9.5% of the class | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 11.86% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Axon Enterprise, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Axon Enterprise, Inc. and the records around it.
Axon Enterprise, Inc. elsewhere on the record
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Axon Enterprise, Inc.
Get an email when Axon Enterprise, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Axon Enterprise, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Axon Enterprise, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Axon Enterprise, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-10 | Reported | not named in the filing | 8-K, 2026-07-10 | ||
| 2026-04-10 | Out | Director | 8-K, 2026-04-10 |
Who leads Axon Enterprise, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Matthew McBrady, departure reported (filed 2026-04-10). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Axon Enterprise, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Axon Enterprise, Inc., with the record behind each one.
Find candidates like Director at Axon Enterprise, Inc.Every change, in the filing's words
Reported
On July 8, 2026, Vivek Mohindra and Eiso Kant were appointed to the Board of Directors (the "Board") of Axon Enterprise, Inc. (the "Company") effective immediately.
- The Board also appointed Mr. Mohindra to serve on the Audit Committee and Compensation Committee, and appointed Mr. Kant to serve as a non-voting observer of the Mergers & Acquisitions and Capital Structure Committee of the Board, in each case commencing concurrently with their Board service.
- Messrs. Mohindra and Kant are independent directors, each with an initial term expiring at the Company's 2027 annual meeting of stockholders.
- In connection with their appointments, each of Mr. Mohindra and Mr. Kant was appointed to fill an existing vacancy on the Board.
- The number of restricted stock units subject to each award will equal the applicable dollar value divided by the ninety-day volume weighted average price of the Company's common stock as of the trading day immediately preceding the applicable grant date.
- Each of Messrs. Mohindra and Kant will also receive annual cash compensation of $40,000, with such retainer paid quarterly and prorated for any partial quarter.
- Mr. Mohindra will also receive additional annual cash retainers of $10,000 for service on the Audit Committee and $7,500 for service on the Compensation Committee, with such retainers paid quarterly and prorated for any partial quarter.
- These payments are consistent with the Company's current compensation program for the Board.
Departing: Matthew McBrady, Director
On April 6, 2026, Matthew McBrady notified the Board of Directors (the "Board") of Axon Enterprise, Inc. (the "Company") that he will not stand for re-election as a director at the Company's 2026 Annual Meeting of Shareholders (the "Annual Meeting").
- Mr. McBrady will continue to serve as a director until his term expires at the Annual Meeting.
- Mr. McBrady's decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- The Board greatly appreciates Mr. McBrady's deep commitment, leadership and many contributions to the Board and to the Company's growth and progress during his years of service.
Tools for this story
Each opens in a new tab, filled in for Axon Enterprise, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.